How end-stage renal disease (ESRD)-Medicare developed

Area of Science:

• Nephrology
• Toxicology
• Medical History

Background:

• Uremia is a severe, toxic condition resulting from numerous kidney and systemic diseases.
• It poses a significant threat to cellular health and can be fatal if untreated.
• Historical medical efforts since Hippocrates aimed to understand and manage uremia.

Observation:

• The urgency of uremic deaths in crises like war spurred medical innovation.
• Dialysis and kidney transplantation emerged as effective, albeit complex and costly, treatments.
• The development of these therapies occurred within a single medical generation.

Findings:

• The evolution of substitution therapy for uremia involved medical, social, and national organizational efforts.
• Legislation established end-stage renal disease (ESRD) as a recognized condition.
• The Medicare entitlement program was developed to cover treatment costs for ESRD patients.

Implications:

• Understanding the historical development of ESRD treatment provides insights into healthcare policy and patient advocacy.
• The story highlights the intersection of medical science, industrial technology, and governmental action.
• This narrative underscores the societal effort to prolong lives affected by kidney disease.